These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20480453)

  • 41. Indirect effects of childhood pneumococcal vaccination on pneumococcal carriage among adults and older children in Australian Aboriginal communities.
    Mackenzie G; Carapetis J; Leach AJ; Hare K; Morris P
    Vaccine; 2007 Mar; 25(13):2428-33. PubMed ID: 17030493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
    Pletz MW; Maus U; Krug N; Welte T; Lode H
    Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.
    von Kries R; Siedler A; Schmitt HJ; Reinert RR
    Clin Infect Dis; 2000 Aug; 31(2):482-7. PubMed ID: 10987709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect?
    Moore MR; Whitney CG
    Clin Infect Dis; 2008 Jan; 46(2):183-5. PubMed ID: 18171248
    [No Abstract]   [Full Text] [Related]  

  • 45. Potential benefits from currently available three pneumococcal vaccines for children--population-based evaluation.
    Rückinger S; van der Linden M; Siedler A; von Kries R
    Klin Padiatr; 2011 Mar; 223(2):61-4. PubMed ID: 21271500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Invasive pneumococcal infections among vaccinated children in the United States.
    Park SY; Van Beneden CA; Pilishvili T; Martin M; Facklam RR; Whitney CG;
    J Pediatr; 2010 Mar; 156(3):478-483.e2. PubMed ID: 19962156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Invasive pneumococcal disease in England and Wales: vaccination implications.
    Sleeman K; Knox K; George R; Miller E; Waight P; Griffiths D; Efstratiou A; Broughton K; Mayon-White RT; Moxon ER; Crook DW; ;
    J Infect Dis; 2001 Jan; 183(2):239-246. PubMed ID: 11120930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Vaccination against pneumococcal infection in adults].
    Viejo JL
    Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():26-8. PubMed ID: 20084346
    [No Abstract]   [Full Text] [Related]  

  • 49. Fold-increase in antibody titer upon vaccination with pneumococcal unconjugated polysaccharide vaccine.
    Borgers H; Meyts I; De Boeck K; Raes M; Sauer K; Proesmans M; Moens L; Jeurissen A; Flamaing J; Peetermans WE; Verhaegen J; Bossuyt X
    Clin Immunol; 2012 Nov; 145(2):136-8. PubMed ID: 23026475
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluation of the indirect effects of a pneumococcal vaccine in a community-randomized study.
    Moulton LH; O'Brien KL; Reid R; Weatherholtz R; Santosham M; Siber GR
    J Biopharm Stat; 2006; 16(4):453-62. PubMed ID: 16892907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serotype replacement in invasive pneumococcal disease: where do we go from here?
    Hanage WP
    J Infect Dis; 2007 Nov; 196(9):1282-4. PubMed ID: 17922390
    [No Abstract]   [Full Text] [Related]  

  • 52. Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.
    Wuorimaa T; Dagan R; Väkeväinen M; Bailleux F; Haikala R; Yaich M; Eskola J; Käyhty H
    J Infect Dis; 2001 Nov; 184(9):1211-5. PubMed ID: 11598848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduction of carriage and transmission of Streptococcus pneumoniae: the beneficial "side effect" of pneumococcal conjugate vaccine.
    Azzari C; Resti M
    Clin Infect Dis; 2008 Oct; 47(8):997-9. PubMed ID: 18781870
    [No Abstract]   [Full Text] [Related]  

  • 54. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
    Melegaro A; Edmunds WJ
    Vaccine; 2004 Oct; 22(31-32):4203-14. PubMed ID: 15474710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting.
    Beall B
    Expert Rev Vaccines; 2007 Jun; 6(3):297-300. PubMed ID: 17542743
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants.
    Yu X; Gray B; Chang S; Ward JI; Edwards KM; Nahm MH
    J Infect Dis; 1999 Nov; 180(5):1569-76. PubMed ID: 10515817
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.
    Rückinger S; van der Linden M; Reinert RR; von Kries R; Burckhardt F; Siedler A
    Vaccine; 2009 Jun; 27(31):4136-41. PubMed ID: 19406190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states.
    Imöhl M; Reinert RR; van der Linden M
    Int J Med Microbiol; 2010 Apr; 300(4):237-47. PubMed ID: 19604721
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How many is enough? Will conjugated pneumococcal vaccines with more serotypes and fewer doses work better?
    Lu CY; Huang LM
    J Formos Med Assoc; 2011 Feb; 110(2):67-9. PubMed ID: 21377059
    [No Abstract]   [Full Text] [Related]  

  • 60. The scope for pneumococcal vaccines that do not prevent transmission.
    Flasche S
    Vaccine; 2017 Oct; 35(45):6043-6046. PubMed ID: 28982625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.